Purpose: To evaluate treatment results and prognostic factors, pediatric pa
tients with nasopharyngeal carcinoma were reviewed.
Materials and methods: Thirty-two patients at the age of 16 and younger wer
e treated for nasopharyngeal carcinoma. One patient had WHO type I, 15 had
WHO type II, and 14 had WHO type III histology. All patients were treated w
ith radiotherapy, median dose to nasopharynx and involved nodes was 70 Gy (
range 60-70.4 Gy), three patients received intracavitary booster dose of 24
Gy in three fractions, 12 patients were also given from two to four course
s of platinum based neo-adjuvant chemotherapy.
Results: Twenty-three patients are alive and well with a median follow-up o
f 107 months. Ten and 15 years loco-regional control (LRC) and overall surv
ival (OS) rates were 82.5, 68.7 and 72.7, 62.4%, respectively. Patient age,
size of the lymph node and prolongation of overall external radiotherapy t
ime were found to be the prognostic factors in univariate analysis, however
the only factor remained significant after multivariate analysis was the s
ize of the lymph node on LRC. Almost all long-term survivors experienced mo
derate to severe complications yielding complication free survival rate of
10.9% at 15 years. (C) 2001 Elsevier Science Ireland Ltd. All rights reserv
ed.